OTCMKTS:ERRFY

Eurofins Scientific Competitors

$9.96
+0.48 (+5.08 %)
(As of 05/7/2021 08:28 PM ET)
Add
Compare
Today's Range
$9.96
$9.96
50-Day Range
$9.48
$21.00
52-Week Range
$3.03
$30.00
Volume387,600 shs
Average Volume10,644 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Eurofins Scientific (OTCMKTS:ERRFY) Vs. EXETF, MLCPF, and SQIDF

Should you be buying ERRFY stock or one of its competitors? Companies in the sector of "health services" are considered alternatives and competitors to Eurofins Scientific, including Extendicare (EXETF), Medipharm Labs (MLCPF), and SQI Diagnostics (SQIDF).

Extendicare (OTCMKTS:EXETF) and Eurofins Scientific (OTCMKTS:ERRFY) are both health services companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, institutional ownership and risk.

Valuation and Earnings

This table compares Extendicare and Eurofins Scientific's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ExtendicareN/AN/AN/AN/AN/A
Eurofins ScientificN/AN/AN/AN/AN/A

Profitability

This table compares Extendicare and Eurofins Scientific's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ExtendicareN/AN/AN/A
Eurofins ScientificN/AN/AN/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for Extendicare and Eurofins Scientific, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Extendicare03002.00
Eurofins Scientific25302.10

Extendicare presently has a consensus price target of $6.8333, suggesting a potential upside of 5.94%. Given Extendicare's higher probable upside, equities analysts plainly believe Extendicare is more favorable than Eurofins Scientific.

Summary

Eurofins Scientific beats Extendicare on 2 of the 3 factors compared between the two stocks.

Medipharm Labs (OTCMKTS:MLCPF) and Eurofins Scientific (OTCMKTS:ERRFY) are both health services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership.

Profitability

This table compares Medipharm Labs and Eurofins Scientific's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medipharm LabsN/AN/AN/A
Eurofins ScientificN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations and price targets for Medipharm Labs and Eurofins Scientific, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medipharm Labs0000N/A
Eurofins Scientific25302.10

Valuation & Earnings

This table compares Medipharm Labs and Eurofins Scientific's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medipharm LabsN/AN/AN/AN/AN/A
Eurofins ScientificN/AN/AN/AN/AN/A

Summary

Eurofins Scientific beats Medipharm Labs on 1 of the 1 factors compared between the two stocks.

SQI Diagnostics (OTCMKTS:SQIDF) and Eurofins Scientific (OTCMKTS:ERRFY) are both health services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and price targets for SQI Diagnostics and Eurofins Scientific, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
SQI Diagnostics0000N/A
Eurofins Scientific25302.10

Earnings and Valuation

This table compares SQI Diagnostics and Eurofins Scientific's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SQI DiagnosticsN/AN/AN/AN/AN/A
Eurofins ScientificN/AN/AN/AN/AN/A

Profitability

This table compares SQI Diagnostics and Eurofins Scientific's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SQI DiagnosticsN/AN/AN/A
Eurofins ScientificN/AN/AN/A

Summary

Eurofins Scientific beats SQI Diagnostics on 1 of the 1 factors compared between the two stocks.


Eurofins Scientific Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Extendicare logo
EXETF
Extendicare
0.6$6.45+0.8%$0.00N/A0.00Upcoming Earnings
MLCPF
Medipharm Labs
0.2$2.57+0.0%$0.00N/A0.00
SQI Diagnostics logo
SQIDF
SQI Diagnostics
0.5$0.24+1.6%$0.00N/A0.00Gap Down
This page was last updated on 5/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.